Targeted Whole-Exome Sequencing of Tumor and Germline
Corresponding Organization :
Other organizations : Dana-Farber Cancer Institute, Harvard University, Bristol-Myers Squibb (United States), Bluebird Bio (United States), VA Boston Healthcare System
Variable analysis
- Tumor sample generated from CD138+ cells collected after the second infusion
- Mutations called by Mutect2
- Allele-specific copy number calls
- Ploidy and purity of the sample
- Peripheral blood mononuclear cells used as germline control
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!